Vince J. Burgess

Chairman, President & Chief Executive Officer at Acutus Medical, Inc.

Vince J. Burgess

Vince J. Burgess

Chairman, President & Chief Executive Officer at Acutus Medical, Inc.

Overview
Career Highlights

Advanced Imaging Systems, Inc.
Acutus Medical, Inc.

RelSci Relationships

913

Number of Boards

7

Birthday

1965

Age

54

Relationships
RelSci Relationships are individuals Vince J. Burgess likely has professional access to. A relationship does not necessarily indicate a personal connection.

Partner at OrbiMed Advisors LLC

Relationship likelihood: Strong

Founding General Partner at OrbiMed Advisors LLC

Relationship likelihood: Strong

Former Chief Executive Officer at Metronom Health, Inc.

Relationship likelihood: Strong

Partner at OrbiMed Advisors LLC

Relationship likelihood: Strong

President & Chief Executive Officer at Sonendo, Inc.

Relationship likelihood: Strong

General Partner at Advent Venture Partners LLP

Relationship likelihood: Strong

General Partner at OrbiMed Advisors LLC

Relationship likelihood: Strong

Co-Founder at Edwards Lifesciences Cardiaq LLC

Relationship likelihood: Strong

Co-Founder at Edwards Lifesciences Cardiaq LLC

Relationship likelihood: Strong

Chief Executive Officer at Endologix, Inc.

Relationship likelihood: Strong

Paths to Vince J. Burgess
Potential Connections via
Relationship Science
You
Vince J. Burgess
Chairman, President & Chief Executive Officer at Acutus Medical, Inc.
Education
BS in Business Administration

University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA.

MBA

Founded in the depth of the Great Depression, UCLA Anderson School of Management now ranks among the top-tier business schools in the world. An award-winning faculty renowned for research and teaching, highly selective admissions, successful alumni and world-class facilities combine to provide an extraordinary learning environment in the heart of Southern California.

MBA Unknown

UCLA's primary purpose as a public research university is the creation, dissemination, preservation and application of knowledge for the betterment of our global society. To fulfill this mission, UCLA is committed to academic freedom in its fullest terms: We value open access to information, free and lively debate conducted with mutual respect for individuals, and freedom from intolerance. In all of our pursuits, we strive at once for excellence and diversity, recognizing that openness and inclusion produce true quality. These values underlie our three institutional responsibilities. Learning and teaching at UCLA are guided by the belief that undergraduate, graduate and professional school students and their teachers belong to a community of scholars. This community is dedicated to providing students with a foundational understanding of a broad range of disciplines followed by the opportunity for in-depth study in a chosen discipline. All members of the community are engaged together in discovering and advancing knowledge and practice. Learning occurs not only in the classroom but also through engagement in campus life and in communities and organizations beyond the university.

Career History
Partner
1994 - 2002

Sorrento Associates invests in emerging growth companies located in Southern California. The firm focuses on in investments in the following sectors: medical devices, biotechnology, communications, enterprise software, electronics/hardware, enabling Internet technologies, e-commerce, specialty retail and distribution.Sorrento looks for companies with experienced management teams that have demonstrated that there is a large market opportunity for their products and services. They seek companies with the potential to grow to at least $50 million in revenues within 5 years. The firm typically invests $1 million to $2 million in three to five new companies per year. They reserve capital for follow-on investments, typically investing $5 million to $10 million over the life of each company. Initial investments are typically Series A or Series B preferred rounds. Sorrento often serves as the lead investor bringing in additional financing from institutional investors. For capital intensive businesses, the firm usually participates in investment syndicates led by another venture firms. Sorrento seeks a return of 30% per year. They participate on the Board of Directors of all of their portfolio companies.

Venture Partner
Prior - 2015

OrbiMed focuses exclusively on global investments across the entire spectrum of private and publicly-traded life sciences companies. They seek to invest in the most promising investment opportunities regardless of a company's stage of development. The firm invests at all stages of development from private start-ups and university spinouts to the largest global pharmaceutical companies. OrbiMed focuses on companies involved in drug development, drug discovery and medical devices, with particular emphasis on mid-stage private companies. Investments typically range from $5 million to $40 million. OrbiMed is generally a lead investor and takes an active role on their portfolio companies' boards of directors

President
2000 - 2010

Advanced Imaging Systems, Inc. provides document imaging products. Its services include data entry, cloud storage, document and record management, document conversion and scanning, electronic forms, scan-to-zero, email management, and workflow automation. The company was founded by Madeleine Solomon in 1972 and is headquartered in Pineville, NC.

Boards & Committees
Director
2012 - Current

Edwards Lifesciences Cardiaq LLC operates as a medical device company which develops technologies for percutaneous mitral heart valve replacement. The firm focuses on mitral regurgitation which is the most commonly occurring heart valve disease. The company was founded by Arshad Quadri and J. B. Ratz in 2007 and is headquartered in Irvine, CA.

Director
Current

Acutus Medical, Inc. develops medical devices and equipment in electrophy. It develops electrophysiological mapping systems for the treatment of cardiac arrhythmias, such as atrial fibrillation, and ventricular tachycardia. The company was founded by Randell L. Werneth and Christoph Scharf in 2011 and is headquartered in San Diego, CA.

Executive Chairman
Current

Ornim, Inc. develops medical monitoring tools for the measurement of blood flow and oxygen saturation in patients. The firm offers CerOx, a non-invasive monitor, which provides real-time data on oximetry and blood flow measurements of specific tissue. Its products are used for applications in neurological treatments and cardiac surgery. The company was founded by Revital Shechter and Michal Balberg in 2004 and is headquartered in Dedham, MA.

Transactions
Details Hidden

Acutus Medical, Inc. raised money in a private placement transaction

Details Hidden

Acutus Medical, Inc. raised money in a private placement transaction

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Vince J. Burgess. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Vince J. Burgess's profile does not indicate a business or promotional relationship of any kind between RelSci and Vince J. Burgess.